Integrated Diagnostics Holdings plc (IDGXF)
- Previous Close
0.2830 - Open
0.2830 - Bid 0.3069 x --
- Ask 0.3670 x --
- Day's Range
0.2830 - 0.2830 - 52 Week Range
0.2830 - 0.4720 - Volume
2,000 - Avg. Volume
209 - Market Cap (intraday)
201.139M - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
8.05 - EPS (TTM)
0.0400 - Earnings Date Apr 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 8, 2021
- 1y Target Est
--
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.
www.idhcorp.com6,309
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IDGXF
View More
Performance Overview: IDGXF
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IDGXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IDGXF
View MoreValuation Measures
Market Cap
200.56M
Enterprise Value
195.05M
Trailing P/E
8.99
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.70
Price/Book (mrq)
3.51
Enterprise Value/Revenue
1.74
Enterprise Value/EBITDA
4.75
Financial Highlights
Profitability and Income Statement
Profit Margin
18.84%
Return on Assets (ttm)
11.79%
Return on Equity (ttm)
30.56%
Revenue (ttm)
5.72B
Net Income Avi to Common (ttm)
1.08B
Diluted EPS (ttm)
0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.75B
Total Debt/Equity (mrq)
42.07%
Levered Free Cash Flow (ttm)
1.33B